Latest Pharma news... Feb 23
FDA clearance leads to first commercial INDfor LSD, enabling initiation of Phase 2b dose-optimization trials of MM-120 in early 2022 - ... Jan 31
Indicated for the prevention of Migraine Headache in chronic migraineurs... Nov 30
... Nov 03
Latest Pharma News update... Aug 26
Sorrento intends to combine a variety of its proprietary mAbs in conjunction with the ADNAB technology platform... Apr 28
Latest FDA News Update... Mar 18
Sorrento receives USFDA clearance to start a clinical trial of Anti-CD47 Antibody, discovered from fully human G-MAB library, for treatment of multiple malignancies ... Mar 03
Roche receives first USFDA clearance for urine sample type for BK virus quantitative test to aid in the improvement of care for transplant patients ... Feb 13
Fortress Biotech declares US FDA has granted breakthrough therapy designation for CUTX-101, Copper Histidinate, for the treatment of Menkes Disease ... Dec 16
The company plans to begin a Phase 1/2 clinical trial of KB-0742 in patients with advanced solid tumours in the first quarter of ... Dec 08
The company believes that OTL-200 offers tremendous potential to transform the lives of many young patients with MLD... Nov 21
Eli Lilly’s neutralizing antibody bamlanivimab receives US FDA emergency use authorization for the treatment of recently diagnosed COVID-19... Nov 12
Ligand’s Partner Sedor Pharmaceuticals receives US FDA approval for SESQUIENT for the treatment of status epilepticus in adult and paediatric patients ... Nov 07
This trial will enroll approximately 330 HR+/HER2- mBC patients in Mainland China, Taiwan and South Korea... Nov 02
... Nov 02
Roche receives FDA approval for the cobas EGFR mutation test v2 as the first companion diagnostic test for expanded EGFR TKI therapies in patients with ... Oct 30
Genprex receives conditional FDA acceptance of proprietary name REQORSA for lead drug candidate for the treatment of non-small cell lung cancer ... Oct 30
The comprehensive portfolio is the first of several planned plating releases for the distal extremities ... Oct 21
Karolinska Development's portfolio company Aprea Therapeutics receives FDA clearance to initiate Phase 1 study of APR-548 ... Oct 08
Oral Covid vaccine gains ground... Sep 18
... Apr 30
Fourth FDA clearance makes Aidoc the comprehensive solution for radiology AI ... Jan 14
-Advertisements-
Wednesday, April 24, 2024
